Demonstration of a chronic myelogenous leukemia clone in acute myelogenous leukemia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeon, Byung Ryul | - |
dc.contributor.author | Kim, Se Hyung | - |
dc.contributor.author | Park, Sung Kyu | - |
dc.contributor.author | Park, Rojin | - |
dc.contributor.author | Hong, Dae Sik | - |
dc.contributor.author | Lee, You Kyoung | - |
dc.date.accessioned | 2021-08-11T18:45:42Z | - |
dc.date.available | 2021-08-11T18:45:42Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 0970-938X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/9912 | - |
dc.description.abstract | In the present study, we report a case of a 58-year-old female patient presenting with Philadelphia-chromosome (Ph)-negative blast cells and Ph-positive mature cells at diagnosis. The complete blood cell count showed the patient had a white blood cell count of 35.5 x 10(9)/L and a differential blast count of 62%. A bone marrow biopsy showed closely packed marrow with blast cell infiltration. Blasts were weakly positive for MPO stain, but negative for PAS and ANAE stains. Moreover, blasts tested positive for CD34, CD13, CD117, CD15, CD33, and CD7 and negative for TdT, CD3, CD22, and CD19 in cytometric immunophenotyping experiments. The patient, who had the karyotype 46, XX,t(9; 22) (q34; q11.2) [14]/45, XX, inv(3)(q21q26.2),-7[4], was therefore diagnosed as having AML. Fluorescence in situ hybridization (FISH) showed a decrease in Ph-positive clones and an increase in monosomy 7positive clones after CD34-positive cell enrichment, suggesting that the blasts were primarily Phnegative. This case highlights the necessity of analyzing the cytogenetic characteristics of blasts to better understand the nature of the disease when only a fraction of the cells are Ph-positive. | - |
dc.format.extent | 3 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Scientific Publishers | - |
dc.title | Demonstration of a chronic myelogenous leukemia clone in acute myelogenous leukemia | - |
dc.type | Article | - |
dc.publisher.location | 인도 | - |
dc.identifier.scopusid | 2-s2.0-84988649059 | - |
dc.identifier.wosid | 000393482000020 | - |
dc.identifier.bibliographicCitation | Biomedical Research (India), v.27, no.4, pp 1099 - 1101 | - |
dc.citation.title | Biomedical Research (India) | - |
dc.citation.volume | 27 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1099 | - |
dc.citation.endPage | 1101 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | CHRONIC MYELOID-LEUKEMIA | - |
dc.subject.keywordPlus | ACUTE MYELOBLASTIC-LEUKEMIA | - |
dc.subject.keywordPlus | IMATINIB TREATMENT | - |
dc.subject.keywordPlus | PHILADELPHIA-CHROMOSOME | - |
dc.subject.keywordPlus | INTERFERON THERAPY | - |
dc.subject.keywordPlus | ABNORMALITIES | - |
dc.subject.keywordPlus | MONOSOMY-7 | - |
dc.subject.keywordPlus | HEMATOPOIESIS | - |
dc.subject.keywordPlus | EMERGENCE | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | AML | - |
dc.subject.keywordAuthor | CML | - |
dc.subject.keywordAuthor | BCR/ABL1 | - |
dc.subject.keywordAuthor | CD 34 enrichment | - |
dc.subject.keywordAuthor | Monosomy 7 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.